Biocryst Pharmaceuticals, Inc.
Get Full AccessDescription
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase I clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. BioCryst Pharmaceuticals, Inc. has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. The company was founded in 1986 and is headquartered in Durham, North Carolina.
-
Headquarters:4505 Emperor Boulevard Suite 200, Durham, North Carolina, United States
More -
Phone Number: +1 919-859-1302
-
Website: https://www.biocryst.com
-
Employees:231
-
Revenue:$10 - 50M
-
Legal Name:Biocryst Pharmaceuticals, Inc.
-
Biocryst Pharmaceuticals, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
NYSE: BCRX
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Biocryst Pharmaceuticals, Inc.
-
Where are Biocryst Pharmaceuticals, Inc.'s Headquarters?
Biocryst Pharmaceuticals, Inc.'s Headquarters are in 4505 Emperor Boulevard Suite 200,Durham,North Carolina,United States
-
What is Biocryst Pharmaceuticals, Inc.'s phone number?
Biocryst Pharmaceuticals, Inc.'s phone number is +1 919-859-1302
-
What is Biocryst Pharmaceuticals, Inc.'s stock symbol?
Biocryst Pharmaceuticals, Inc.'s stock symbol is BCRX
-
What is Biocryst Pharmaceuticals, Inc.'s official website?
Biocryst Pharmaceuticals, Inc.'s official website is https://www.biocryst.com
-
What is Biocryst Pharmaceuticals, Inc.'s Revenue?
Biocryst Pharmaceuticals, Inc.'s revenue is $10 - 50M
-
What is Biocryst Pharmaceuticals, Inc.'s NAICS code?
Biocryst Pharmaceuticals, Inc.'s NAICS code is 325412
-
How many employees are working in Biocryst Pharmaceuticals, Inc.
Biocryst Pharmaceuticals, Inc. has 231 employees
-
What is Biocryst Pharmaceuticals, Inc.'s Industry?
Biocryst Pharmaceuticals, Inc. is in the industry of Biotechnology